Alanine aminotransferase decrease in HIV-hepatitis C virus co-infected patients responding to antiretroviral therapy

AIDS

Volumn 17, Issue 14, 2003, Pages 2141-2142

  Aceti, Antonio ^a   Pasquazzi, Caterina ^a   Zechini, Barbara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; COMORBIDITY; CORRELATION ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; LIVER FIBROSIS; LIVER TOXICITY; LYMPHOCYTE COUNT; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; ANTI-RETROVIRAL AGENTS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS;

EID: 0142030002     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200309260-00023     Document Type: Letter

References (6)

1. Diaz B, Martìn-Carbonero L, Pèrez-Olmeda M, Soriano V. Normalization of liver enzymes in an HIV-hepatitis C virus co-infected patient after potent antiretroviral therapy. AIDS 2002, 16:1193.
2. Aceti A, Pasquazzi C, Zechini B, De Bac C, and the LIVERHAART Group. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in HIV patients: the role of hepatitis B and C virus infection. J Acquir Immune Defic Syndr 2002, 29:41-48.
3. Perez-Olmeda M, Garcia-Samaniego J, Romero M, Soriano V. Hepatitis C viremia in HIV-HCV coinfected patients having immune restoration with HAART. AIDS 2000, 14:212.
4. Puoti M, Gargiulo F, Roldan EQ, Chiodera A, Palvarini L, Spinetti A, et al. Liver damage and kinetics of hepatitis C virus and HIV replication during the early phases of combination antiretroviral treatment. J Infect Dis 2000, 181:2033-2036.
5. Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, et al. Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 2001, 34:283-287.
6. Puoti M, Bonacini M, Spinetti A, Putzolu V, Govindarajan S, Zaltron S, et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 2001; 183: 134-137.